Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:EW CVE:IFR NASDAQ:PCO NASDAQ:PFC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEWEdwards Lifesciences$76.95-1.6%$77.12$64.00▼$83.00$45.18B1.084.54 million shs3.63 million shsIFRInternational Frontier ResourcesC$0.04-22.2%C$0.03C$0.03▼C$0.05C$1.33M1.1428,396 shs4,005 shsPCOPendrell Corporation Class A$634.50$634.50$589.00▼$761.00N/AN/A883 shs10,363 shsPFCPremier Financial$28.04$28.04$22.36▼$29.64$1.00B1.28200,377 shsN/AReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEWEdwards Lifesciences-0.18%-2.31%+0.21%+3.64%+21.03%IFRInternational Frontier Resources0.00%0.00%0.00%0.00%-22.22%PCOPendrell Corporation Class A0.00%0.00%0.00%0.00%0.00%PFCPremier Financial0.00%0.00%0.00%0.00%+21.91%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEWEdwards Lifesciences4.8438 of 5 stars3.34.00.04.03.92.52.5IFRInternational Frontier ResourcesN/AN/AN/AN/AN/AN/AN/AN/APCOPendrell Corporation Class AN/AN/AN/AN/AN/AN/AN/AN/APFCPremier FinancialN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEWEdwards Lifesciences 2.65Moderate Buy$85.9011.64% UpsideIFRInternational Frontier Resources 0.00N/AN/AN/APCOPendrell Corporation Class A 0.00N/AN/AN/APFCPremier Financial 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest IFR, PFC, EW, and PCO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/7/2025EWEdwards LifesciencesWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$84.00 ➝ $88.007/29/2025EWEdwards LifesciencesDaiwa AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Strong-Buy7/29/2025EWEdwards LifesciencesBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$100.007/25/2025EWEdwards LifesciencesThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy7/25/2025EWEdwards LifesciencesWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy7/25/2025EWEdwards LifesciencesJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$80.00 ➝ $85.007/25/2025EWEdwards LifesciencesCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$75.00 ➝ $81.007/25/2025EWEdwards LifesciencesMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$87.00 ➝ $95.007/25/2025EWEdwards LifesciencesTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$81.00 ➝ $82.007/25/2025EWEdwards LifesciencesPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$83.00 ➝ $90.00(Data available from 8/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEWEdwards Lifesciences$5.44B8.31$2.68 per share28.69$17.06 per share4.51IFRInternational Frontier ResourcesN/AN/AC$0.00 per share12.50C($0.02) per shareN/APCOPendrell Corporation Class AN/AN/AN/AN/AN/AN/APFCPremier Financial$243.59M4.13$2.92 per share9.59$27.30 per share1.03Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEWEdwards Lifesciences$4.17B$6.9511.0727.983.7872.96%15.01%11.56%10/23/2025 (Estimated)IFRInternational Frontier Resources-C$3.86M-C$0.02N/A∞N/AN/A-501.04%-76.75%N/APCOPendrell Corporation Class AN/AN/A0.00∞N/AN/AN/AN/AN/APFCPremier Financial$71.40M$1.9914.0911.68N/A16.12%7.66%0.87%N/ALatest IFR, PFC, EW, and PCO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/24/2025Q2 2025EWEdwards Lifesciences$0.62$0.67+$0.05$0.56$1.49 billion$1.53 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEWEdwards LifesciencesN/AN/AN/AN/AN/AIFRInternational Frontier ResourcesN/A3.08%N/AN/AN/APCOPendrell Corporation Class AN/AN/AN/AN/AN/APFCPremier Financial$1.244.42%N/A62.31%N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEWEdwards Lifesciences0.064.683.87IFRInternational Frontier Resources8.430.360.22PCOPendrell Corporation Class AN/AN/AN/APFCPremier Financial0.420.950.93Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEWEdwards Lifesciences79.46%IFRInternational Frontier ResourcesN/APCOPendrell Corporation Class AN/APFCPremier Financial66.14%Insider OwnershipCompanyInsider OwnershipEWEdwards Lifesciences0.34%IFRInternational Frontier Resources13.49%PCOPendrell Corporation Class A41.46%PFCPremier Financial2.22%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEWEdwards Lifesciences15,800587.10 million585.10 millionOptionableIFRInternational Frontier Resources638.09 millionN/ANot OptionablePCOPendrell Corporation Class AN/AN/AN/ANot OptionablePFCPremier Financial1,02335.84 million35.05 millionOptionableIFR, PFC, EW, and PCO HeadlinesRecent News About These CompaniesWesBanco, Inc.: WesBanco Announces First Quarter 2025 Financial ResultsMay 3, 2025 | finanznachrichten.deWesBanco Completes Acquisition of Premier Financial, Expands Regional FootprintMarch 3, 2025 | monitordaily.comMWesBanco, Inc. Completes Acquisition of Premier Financial Corp. and Appoints DirectorsFebruary 28, 2025 | prnewswire.comWesBanco and Premier Financial receive final regulatory approval for mergerFebruary 12, 2025 | wfmj.comWWesBanco, Inc. and Premier Financial Corp. announce pending mergerFebruary 12, 2025 | hometownstations.comHWesBanco, Premier merger gets regulatory nodFebruary 12, 2025 | msn.comWesBanco, Inc. and Premier Financial Corp. Announce Regulatory Approvals for Pending MergerFebruary 12, 2025 | prnewswire.comBest Income Stocks to Buy for February 4thFebruary 4, 2025 | zacks.comWhat Makes Premier Financial (PFC) a Strong Momentum Stock: Buy Now?January 29, 2025 | zacks.comPremier financial director Lanier sells $83,460 in sharesJanuary 28, 2025 | msn.comPremier Financial Corp. Reports Mixed 2024 ResultsJanuary 23, 2025 | tipranks.comPremier Financial (PFC) Tops Q4 Earnings and Revenue EstimatesJanuary 21, 2025 | zacks.comWhere are the Opportunities in (PFC)January 7, 2025 | news.stocktradersdaily.comNLong Term Trading Analysis for (PFC)December 27, 2024 | news.stocktradersdaily.comNPremier Financial Corp Share Price (PFC.US)December 22, 2024 | lse.co.ukPremier Bank’s Kindness Movement surpasses $180,000 in community support in the southern marketDecember 18, 2024 | hometownstations.comH(PFC) Technical Pivots with Risk ControlsDecember 16, 2024 | news.stocktradersdaily.comNWesBanco, Premier Financial shareholders vote to approve mergerDecember 11, 2024 | msn.comWesBanco, Inc. and Premier Financial Corp. Announce Shareholder Approvals of Merger AgreementDecember 11, 2024 | prnewswire.comWhen (PFC) Moves Investors should ListenNovember 25, 2024 | news.stocktradersdaily.comNNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesAmerica Wants Drone Dominance: Are These Stocks Ready to Soar?By Chris Markoch | July 20, 2025Super Micro Computer Sees Unusual Volume—Catalyst Ahead?By Gabriel Osorio-Mazilli | July 25, 20253 Catalysts Driving Plug Power’s Turnaround CaseBy Jeffrey Neal Johnson | July 18, 20255 Stocks to Buy and Hold for the Rise of Physical AIBy Thomas Hughes | July 23, 2025Rivian Stock Rallies as Robotaxi Buzz BuildsBy Gabriel Osorio-Mazilli | July 24, 2025IFR, PFC, EW, and PCO Company DescriptionsEdwards Lifesciences NYSE:EW$76.95 -1.21 (-1.55%) Closing price 03:59 PM EasternExtended Trading$76.92 -0.03 (-0.04%) As of 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.International Frontier Resources CVE:IFRC$0.04 -0.01 (-22.22%) As of 08/1/2025International Frontier Resources Corporation acquires, develops, exploits, and produces oil and natural gas in Mexico, Canada, and the United States. The company has oil and natural gas interests in the Central Mackenzie Valley, Northwest Territories, Canada; and owns mineral titles covering an area of approximate 15,200 acres located in Northwest Montana. It has a license contract for the extraction of hydrocarbons in the Tecolutla Block located in Veracruz, Mexico; and holds an interest in significant discovery licenses situated in Northwest Territories. The company was founded in 1995 and is based in Calgary, Canada.Pendrell Corporation Class A NASDAQ:PCOPremier Financial NASDAQ:PFCPremier Financial Corp., through its subsidiaries, provides various banking services. It offers demand, checking, money market, and savings accounts, as well as certificates of deposits and certificates of deposit account registry service; and investment products. The company also provides residential and commercial real estate, commercial, construction, home improvement and home equity, installment, and consumer loans. In addition, it invests in the U.S. treasury and federal government agency obligations, obligations of states and political subdivisions, mortgage-backed securities that are issued by federal agencies, residential collateralized mortgage obligations, and corporate bonds. Further, the company offers property and casualty, life, and group health insurance agency services; mezzanine funding services; and digital banking services, which include mobile banking, zelle, online bill pay, and online account opening, as well as the MoneyPass ATM network. It operates in Ohio, Michigan, Indiana, Pennsylvania, and West Virginia. The company was formerly known as First Defiance Financial Corp. and changed its name to Premier Financial Corp. in June 2020. Premier Financial Corp. was founded in 1920 and is headquartered in Defiance, Ohio. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Intel's White House Reset: From Political Storm to a Clearer Sky AST SpaceMobile on Track for Explosive Upside Oklo’s Stock Is Set up for a Correction—Buy It When It Bounces If Qualcomm Holds $145, Its Next Move Could Be Massive Alphabet Reclaims $200 Threshold—Bull Run Reignited? Brutal 2025 for Sarepta—Analysts Still Call for 179% Upside Apple & Trump: $100B Investment, Tariffs News Push Shares Up 13% How Vertiv Is Cashing in on AI's Power Crisis Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.